St. Luke's Health System - Welcome
  Execute Search
 




SATURDAY, OCTOBER 11, 2014
7:00 – 7:55 a.m.    Registration and Breakfast

7:55 – 8:00 a.m.    Welcoming Remarks
                            John M. Vierling, M.D.


Plenary Session I:
Metabolic Liver Diseases and Liver Diseases in Pregnancy for Clinicians - Moderator: Stephen A. Harrison, MD

8:00 – 8:25 a.m.    Non-Alcoholic Fatty Liver Disease: Practical Approaches to Diagnosis and Therapy – Stephen A. Harrison, MD

8:25 – 8:50 a.m.    Alcoholic Hepatitis: Steroids, Pentoxyfylline, Transplant or Other? – Saira Khaderi, MD

8:50– 9:15 a.m.     Hemochromatosis: Diagnosis of Patients without C282Y or H63D Mutations – Gagan Sood, MD
                               
9:15 – 9:40 a.m.    Liver Disease in Pregnancy: How to Help Moms, Fetuses and Obstetricians – Risë Stribling, MD

9:40– 10:05 a.m.  Case-Based Questions for Audience and Panel (Harrison, Khaderi, Sood, Stribling) – Moderator: Khozema Hussain, MD

     Case Vignettes: Transplant Hepatology Fellows

10:05 – 10:20 a.m. BREAK #1

Plenary Session II:  Cirrhosis and Its Complications for the Clinician - Moderator: Guadalupe Garcia-Tsao, MD

10:20 – 10:45 a.m.  Cirrhosis: What Clinicans Can Do to Prevent Progression and Complications of Portal Hypertension - Guadalupe Garcia-Tsao, MD

10:45 – 11:10 a.m.  Bacterial Infections in Cirrhotic Patients: Changing Paradigms, Gut Flora and Lethality – Alejandro Restrepo, MD

11:10 – 11:35 p.m.  Pulmonary Complications of Cirrhosis: Early Recognition and Management - Norman Sussman, MD

11:35 – 12:00 p.m.  Hepatic Encephalopathy: Prevention and Therapy for Covert and Overt – Willis C. Maddrey, MD

12:00 – 12:25 p.m.  Hepatocellular Carcinoma: Impact of Therapy for Primary Liver Diseases and Surveillance – Hashem El-Serag, MD, MPH

12:25 – 12:50 p.m.  Case-Based Questions for the Audience and Panel (Garcia-Tsao, Restrepo, Sussman, Maddrey, El-Serag) - Moderator Gagan Sood, MD
                             Case Vifnettes: Transplant Hepatology Fellows
 
12:50 – 1:40 p.m.    Lunch with the Faculty

Plenary Session III:  Chronic Viral Heapatitis in Clinical Practice - Moderator: Eugene Schiff, MD

1:40 – 2:05 p.m.     Current and Imminent Therapies for HCV Genotypes 1, 2, 4, 5 and 6 Infections – Eugene Schiff, MD
           
2:05 – 2:30 p.m.     Current and Imminent Options for Difficult to Treat Populations: HCV Genotype 3, HIV-HCV Co-infection, Decompensated Cirrhosis, ESRD – John M. Vierling, MD

2:30 – 2:55 p.m.     Chronic HEV Infection: Epidemiology, Diagnosis and Therapy – Prasun Jalal, MD

2:55 – 3:20 p.m.     HBV: Translating Competing Guidelines into Clinical Practice – F. Blaine Hollinger, MD

3:20 – 3:45 p.m.    Case-Based Questions for Audience and Panel (Schiff, Vierling, Jalal, Phan) Moderator: F. Blaine Hollinger, MD
                            Case Vignettes: Transplant Hepatology Fellows

3:45 – 4:20 p.m.    Expert Predictions: Progress in Next 12 Months (El-Serag; Garcia-Tsao; Maddrey; Schiff; Vierling)

4:20 p.m.             Prize Drawing and Adjorn